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ABSTRACT
Objective: Swertia chirata has been used in traditional and folklore medicine to treat several ailments such as hepatic disorders. However, the 
mechanistic and experimental justification to its traditional use is lacking. The present study was aimed to investigate the hepatoprotective potential 
of S. chirata during hypoxia (HYP)-induced hepatic damage in Wistar rats and to determine the underlying mechanism.
Methods: Hydroalcoholic extract of S. chirata was prepared using Soxhlet extraction. Animals were divided into six groups (n=5). Animals in the HYP 
groups were subjected to HYP for 3 days (10% O2) to induce oxidative stress and hepatic damage. 50 and 100 mg/kg extract treatments were provided 
orally once daily for 7 days after which animals were sacrificed, and biochemical investigations for oxidative stress, liver function tests, and hepatic 
histopathology were performed.
Results: HYP-induced marked oxidative stress as indicated by the significantly elevated mitochondrial ROS generation, lipid peroxidation, glutathione, 
and depleted catalase levels. Liver function test indicated hepatic damage as the levels of serum glutamic-oxaloacetic transaminase, serum glutamic 
pyruvic transaminase, and aspartate transaminase were significantly elevated in HYP animals. S. chirata treatment alleviated oxidative stress and 
improved liver functions in a dose-dependent manner. Liver histopathology confirmed the marked hepatic damage induced by HYP and revealed that 
S. chirata efficiently rescued liver from hypoxic damage.
Conclusion: Hydroalcoholic extract of S. chirata is a potent hepatoprotective intervention which was associated with its potential to alleviate oxidative 
stress and improve liver functions. Moreover, it could find clinical application as a safer and alternative remedy for liver ailments.
Keywords: Swertia chirata, Oxidative stress, Hepatotoxicity, Liver damage, Liver function test, histopathology.
INTRODUCTION
Oxidative stress plays a central role in the development and progression 
of a variety of complications such as hepatotoxicity, neurotoxicity, 
diabetes, and Alzheimer’s disorder [1,2]. Our body is having an 
efficient antioxidant defense in the form of catalase, glutathione (GSH), 
thiols, sulfoxide dismutase, etc., which rapidly neutralize the reactive 
oxygen and nitrogen species (ROS/RNS) [3]. However, our oxidative 
stress defense mechanism is a saturable process. When oxidative 
stress is increased in our body, especially during HYP and diabetes, 
ROS/RNS neutralizing capacity of antioxidant defense is saturated 
and ROS/RNS enters into the circulation. These free radicles interact 
with the biomolecules such as proteins, lipids, DNA, and RNA inhibit 
their normal functioning, leading to the development of a variety of 
complications [3]. The liver is responsible for the metabolism and 
detoxification of a variety of drugs and toxins and, therefore, is on the 
higher risk of the development of oxidative stress-mediated toxicity [4]. 
Oxidative stress is associated with the development of liver toxicity 
and liver disorders such as alcoholic liver disease and non-alcoholic 
steatohepatitis [5]. Moreover, oxidative stress is markedly enhanced 
during hypoxic state which further deteriorates the liver functions 
and is associated with the development and progression of liver 
complications [6-8].
To date, there is no drug available which can counter oxidative 
stress and associated complications. There is an urgent need for the 
screening of some safer and alternative therapeutic strategies which 
can effectively counter oxidative stress and, therefore, may attenuate 
associated complications. Plants have long been exploited as a source 
of safe and efficient therapeutic agents and may provide us with the 
needed antioxidant therapy which can not only alleviate the oxidative 
stress but may also halt the progression of ROS- and RNS-mediated 
complications [9]. Swertia chirata has long been used in Ayurvedic 
and Unani medicine as an antihelminthic, febrifuge, stomach, and liver 
tonic [10,11]. This plant is abundant with a large number of alkaloids 
and flavonoids along with other different phytoconstituents that are 
responsible for its all broad range of medicinal properties [12]. Research 
work focused on S. chirata suggests that plant extract is beneficial in the 
management of liver disorders; however, the mechanism through which 
hepatoprotection is achieved remains unknown to a large extent. In this 
study, we aimed to provide a scientific evidence to the traditional use 
of S. chirata and investigated whether or not plant extract is beneficial 
in the management of HYP-induced hepatotoxicity and investigated its 
effect on oxidative stress as a potential mechanism.
MATERIALS AND METHODS
Material
All the chemicals and reagents used in this study were of analytical grade 
procured from Sigma, Hi-Media, and Loba Chemie, unless otherwise 
specified. Estimation of serum biochemical parameters was performed 
on Hitachi Modular P800 autoanalyzer. Kits for biochemical assays were 
obtained from Roche Diagnostics (Roche Diagnostics K.K., Tokyo, Japan). 
5,50-dithiobisnitrobenzoic acid (DTNB) and 2-thiobarbituric acid (TBA) 
were obtained from the Sigma Chemical Co. (St. Louis, MO, USA).
Sample collection and extraction
Plant species were collected from high altitude regions of Himachal 
Pradesh and Uttarakhand during the month of July–September. 
The plant was identified and authenticated by Prof. (Dr.) Narayan 
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S. Chauhan, Dr. YS Parmar, University of Horticulture and Forestry, 
Sola, Himachal Pradesh, India. The whole plant was used for the 
preparation of the extract. The samples were washed, shade dried at 
room temperature, and coarsely powdered. Extraction was performed 
in a Soxhlet apparatus at 25°C for 72 h in 80% methanol. The extract 
was filtered while hot concentrated under reduced pressure by rotary 
evaporator and lyophilized. Extract yield was calculated and the extract 
was stored at −20°C in a refrigerator until used for further analysis.
Animals
All experimental protocols were performed on male Wistar rats after 
approval from the Institutional Animal Ethics Committee (DIHAR/
IAEC/36/2015). All the experiments were designed and performed 
strictly in accordance with the guidelines of Committee for the Purpose 
of Control and Supervision of Experiments on Animals, Government 
of India. Wistar rats (150–200 g; 8–10 month age) were housed in the 
DIHAR animal house inside polypropylene cages (two animals per cage) 
at the temperature of 23±2°C, 12 h day/light cycle, and 65 ± 5% relative 
humidity. Animals had free access to food and water. All necessary 
precautions were taken to minimize the sufferings to the animals.
Animal groupings
Animals were divided into six groups having five animals in each group 
as follows:
 Group 1 - Control (CTRL) (received 0.3% carboxymethyl cellulose 
as a vehicle orally).
 Group 2 - CTRL + 50 mg/kg S. chirata extract suspended in a vehicle 
(CTRL 50).
 Group 3 - CTRL + 100 mg/kg S. chirata extract suspended in a vehicle 
(CTRL 100).
 Group 4 - HYP (rats exposed to 10% oxygen (O2) for 3 days and 
received vehicle orally).
 Group 5 - HYP + 50 mg/kg S. chirata extract suspended in a vehicle 
(HYP 50).
 Group 6 - HYP + 100 mg/kg S. chirata extract suspended in a vehicle 
(HYP 100).
All the treatments were given orally once daily between 6 and 7 pm for 
7 days.
Induction of HYP
Hypoxic conditions were provided to the animals by placing them 
inside a custom-made HYP chamber linked with O2 and nitrogen (N2) 
cylinders. The concentration of O2 was regulated by infusing N2 into 
the chamber. The hypoxic treatment was given to the rats in the HYP 
chamber at 10% O2 for 3 days.
Animal sacrifice and sample collection
Animals were sacrificed by cervical dislocation and tissues were 
collected for biochemical and histopathological examinations. For 
biochemical evaluation, tissue samples were weighed, homogenized 
in 20 mM hydroxyethyl piperazineethanesulfonic acid (HEPES) buffers 
and stored at 4°C until used. Blood was collected and serum was isolated 
for the evaluation of liver function tests (enzymes). All the samples were 
used within 6 h for the biochemical evaluations. For histopathological 
examinations, tissues were fixed by double circulation by infusing 
phosphate buffer saline (PBS; pH 7.4) followed by a fixing solution of 
2% glutaraldehyde and 2% formaldehyde. Tissues were collected and 
stored in fixing solution at room temperature.
Biochemical evaluation
Isolation of mitochondria
Mitochondria were isolated using a method described by Brown 
et al. [13], with slight modifications. Briefly, dissected tissue was weighed 
and homogenized by Teflon hand homogenizer in homogenizing buffer 
(five volumes). Homogenizing buffer consisted of 1 mM ethylene glycol 
tetraacetic acid (EGTA), 215 mM mannitol, 75 mM sucrose, 0.1% bovine 
serum albumin, 20 mM HEPES, and pH adjusted to 7.2 with potassium 
hydroxide. Homogenate was centrifuged at 10,000 g at 4°C for 5 min. 
The resulting pellet was suspended in 500 µl homogenizing buffer. To 
pellet out the mitochondria, centrifugation was carried out again at 
13,000 g for 10 min. The pellet obtained after centrifugation was washed 
in the EGTA-containing buffer and centrifuged at 10,000 g for 10 min, 
and suspended in the same buffer at a concentration of 10 mg/ml.
Mitochondrial ROS generation
Mitochondrial ROS generation was evaluated in accordance with 
the method described by Wasilewski and Wojtczak [14], with 
some necessary modifications. Briefly, approximately 10 µl of 
mitochondria (15 µg protein equivalent) were incubated with the 
respiration buffer containing 5 mM pyruvate, 2.5 mM malate, and 
10 M of dichlorodihydrofluorescein diacetate for 20 min at 37°C. After 
incubation, fluorescence as a result of ROS generation was quantified 
using a Cary Eclipse fluorimeter (Varian, Palo Alto, USA) (excitation 
485 nm and emission 582 nm) and related to total protein content. 
Moreover, carbonylcyanide-4-(trifluoromethoxy)-phenylhydrazone 
was added to inhibit the interference from the membrane potential-
dependent ROS production.
Lipid peroxidation
Lipid peroxidation was assayed by the method of Mehta et al. [15], with 
some necessary modifications. Briefly, 500 µl of mitochondrial extract 
equivalent of 15 µg protein was diluted with equal volume of Tris-HCl 
buffer (0.1 M, pH 7.4). The reaction mixture was incubated for 2 h at 
37°C with constant shaking inside an incubator. 1000 µl of 10% w/v 
of trichloroacetic acid was added to the reaction mixture, mixed 
thoroughly, and subjected to centrifugation at 8000 rpm for 10 min. 
1500 µl of 0.67% w/v TBA was added to each tube and tubes were 
heated to 100°C for 10 min in a boiling water bath. Reaction tubes were 
cooled under running tap water, centrifuged at 10,000 rpm for 15 min, 
and the absorbance of the supernatant was recorded at 532 nm using 
UV spectrophotometer. The results were expressed as nmol TBARS/mg 
protein.
Catalase activity
Catalase activity was assayed spectrophotometrically at 240 nm, and the 
results were expressed as moles of hydrogen peroxide (H2O2) consumed 
as per the method described by Mehta et al. [15]. The reaction mixture 
consisted of a 500 µl brain homogenate equivalent of 15 µg protein. The 
reaction was initiated by the addition of 32 µl of 30% H2O2. Absorbance 
was recorded every minute for 4 min using UV spectrophotometer, and 
the level of catalase in the homogenate was determined in terms of the 
amount of H2O2 consumed during the 4-min reaction interval.
GSH peroxidase assay
GSH peroxidase activity was determined by the method previously 
described by Necheles et al. [16], with some modifications as per the 
requirements. The reaction mixture consisted of 400 µl of 0.35 M 
phosphate buffer (pH 7.4), 100 µl of 10 mM sodium azide, 200 µl of 
8 mM freshly prepared GSH, 500 µl mitochondrial sample equivalent 
to 15 µg protein, 100 µl of 2.5 mM H2O2, and 1100 µl double-distilled 
water. The reaction mixture was incubated for 5 min at 37oC. 500 µl of 
10% trichloroacetic acid was added to the reaction mixture followed 
by centrifugation at 3500 rpm for 15 min at room temperature. 
500 µl supernatant was diluted with 3000 µl of 0.3 M disodium hydrogen 
phosphate. 1000 µl DTNB (freshly prepared in phosphate buffer pH 7.4) 
was added to the reaction mixture. The reaction mixture was allowed 
to stand for 5 min at room temperature and then its absorbance was 
recorded at 412 nm using a UV spectrophotometer. The results were 
expressed as mg of GSH consumed/min/mg protein.
Liver function test
Serum glutamic-oxaloacetic transaminase (SGOT), serum glutamic 
pyruvic transaminase (SGPT), and serum aspartate transaminase (ALP) 
are the extensively studied biomarkers of the hepatic damage in both 
clinical and preclinical settings. Liver function tests were performed 
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to evaluate the effect of S. chirata extract in HYP-induced liver damage 
in term of SGOT, SGPT, and ALP levels. Levels of these enzymes were 
measured using commercially available kits as per the manufacturer’s 
instructions.
Histopathological examination
Histopathological examination of the liver tissue was performed 
to evaluate the HYP-mediated liver damage and to evaluate the 
hepatoprotective potential of hydroalcoholic leaf extract of S. chirata 
as per the method described by Aboonabi et al. [17]. Briefly, animals 
were anesthetized and tissue was fixed by double circulation technique 
by infusing phosphate buffer saline (pH 7.4) followed by a fixing 
solution of 2% glutaraldehyde and 2% formaldehyde. Tissues were 
collected and stored in fixing solution at room temperature. Tissues 
were embedded into the paraffin wax and 5 µm thick sections were 
prepared using microtome. Sections were stored at room temperature 
and histopathological alterations were detected by staining sections 
with hematoxylin and counterstaining with eosin (hematoxylin-eosin 
staining). Effect of HYP and extract treatment on cellular morphology of 
liver was assessed by analyzing images captured at ×100 magnification.
Statistical analysis
All the statistical analyses were carried out by GraphPad Prism 6. All 
values are expressed as mean ± standard error of the mean. Statistical 
significance was determined by one-way ANOVA followed by Dunnett’s 
post hoc test at *p<0.05, **p<0.01, and ***p<0.001 versus control 
and#p<0.05, ##p<0.01, and###p<0.001 versus HYP.
RESULTS
Extractive yield and phytochemical evaluation
The extractive yield of the hydroalcoholic extraction of S. chirata was 
observed to be 22.37% of the crude plant sample. Phytochemical 
screening was performed, and it revealed the presence of flavonoids, 
alkaloids, glycosides, steroids, terpenoids, tannins, and saponins. 
Volatile oil, fixed oil, proteins, and acidic compounds were not present 
in the plant extract. Moreover, we observed the high amount of phenolic 
and flavonoids presents in the plant extract which might be responsible 
for its antioxidant potential.
Biochemical investigation
Mitochondrial ROS generation
Mitochondrial ROS generation and the effect of hydroalcoholic extract 
of S. chirata on it was determined and the results are depicted in 
Fig. 1a. Subjecting animals to hypoxic stress resulted in high levels of 
oxidative stress as indicated by the significantly (p<0.001) high levels 
of ROS generated in the HYP group when compared to CTRL. ROS levels 
differed non-significantly in control animals treated with plant extract 
at 50 mg/kg and 100 mg/kg dose when compared to CTRL, suggesting 
that plant extract is not associated with enhancing ROS production 
directly. Further, treating hypoxic rats with 50 mg/kg and 100 mg/kg 
dose of S. chirata extract significantly (p<0.01) lowered the generation 
of mitochondrial ROS in a dose-dependent manner when compared to 
HYP animals. These results suggest that S. chirata extract is having good 
antioxidant potential which may aid it the beneficial effects associated 
with extract treatment in the animals.
Lipid peroxidation
Malondialdehyde (MDA) levels are used to determine the levels of 
lipid peroxidation in the biological samples, especially in the animal 
experimentation. We used this method to determine the effect of 
S. chirata extract treatment on the lipid peroxidation in hypoxic rats, and 
the results are depicted in Fig. 1b. We observe a significantly (p<0.001) 
high levels of MDA or lipid peroxidation in HYP animals when compared 
to CTRL, suggesting the development of oxidative stress in HYP animals. 
Treating HYP animals with plant extract resulted in a dose-dependent 
lowering of the lipid peroxidation levels at 50 mg/kg (p<0.05) and 
100 mg/kg (p<0.01) dose. We did not observe any significant lipid 
peroxidation in control animal treated with plant extract and the MDA 
levels in these groups were similar to CTRL, suggesting that plant 
extract is not associated with lipid peroxidation directly.
Catalase activity
Catalase is a strong antioxidant enzyme present in our body which 
is responsible for the detoxification of the ROS generated from the 
electron transport chain in the mitochondria. We evaluated the effect 
of S. chirata extract treatment on the catalase activity during HYP in 
Wistar rats and the results are depicted in Fig. 1c. Our results suggest 
that HYP leads to the saturation of catalase enzyme and its levels 
were observed to be significantly (p<0.001) lower in HYP animals 
when compared to CTRL. Treat hypoxic animals with the plant extract 
resulted in a dose-dependent improvement in catalase levels, and 
catalase activity was observed to be significantly higher in HYP animals 
treated with 50 mg/kg (p<0.05) and 100 mg/kg (p<0.01) plant extract 
when compared to CTRL. Catalase levels were observed to be normal 
in control animals treated with extract when compared to CTRL. These 
results suggest that S. chirata is having an antioxidant potential which 
can be partially attributed to its potential to either upregulate catalase 
activity or prevent its depletion during oxidative stress.
GSH peroxidase assay
Determination of the GSH levels is an established method to estimate 
the level of oxidative stress in the body. We evaluated the effect of 
S. chirata extract treatment on the GSH during HYP in Wistar rats and 
the results are depicted in Fig. 1d. Our results suggest that HYP leads 
to marked oxidative stress as depicted by the significantly (p<0.01) 
reduced GSH levels in HYP animals when compared to control. Treating 
hypoxic animals with the plant extract resulted in a dose-dependent 
elevation in GSH levels at 50 mg/kg (p<0.05) and 100 mg/kg (p<0.05) 
when compared to HYP. Normal animals treated with extract showed 
GSH levels comparable to control.
Liver function tests
HYP-induced hepatic damage and the hepatoprotective effect of 
S. chirata treatment was determined by evaluating liver function tests 
in which we determined the biochemical levels of SGOT, SGPT, and 
ALP (Fig. 2). HYP resulted in a significant (p<0.001) increase in the 
Fig. 1: Effect of Swertia chirata treatment on hypoxia (HYP)-
induced oxidative stress (a) percentage ROS generation, (b) lipid 
peroxidation, (c) percentage catalase activity, (d) percentage 
glutathione levels. Values are represented mean ± standard error 
of the mean. CTRL - control; CTRL 50 - control+50 mg/kg extract; 
CTRL 100 - control+100 mg/kg extract; HYP - hypoxia; HYP 
50 - HYP+50 mg/kg extract; HYP 100 - HYP+100 mg/kg extract. 
*p<0.05; **p<0.01; ***p<0.001 versus CTRL group.#p<0.05, 
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serum levels of SGOT, SGPT, and ALP, indicating the marked damage 
of hepatic cells. Extract treatment exerted a dose-dependent effect 
on hepatic biochemical enzymes. Levels of SGOT, SGPT, and ALP were 
reduced significantly by the extract treatment at 50 mg/kg (p<0.05) 
and 100 mg/kg (p<0.01) extract treatment. These results suggest that 
extract treatment efficiently protected hepatic cells from HYP-mediated 
damage. Moreover, extract treatment had no hepatotoxic effect of its 
own as the levels of SGOT, SGPT, and ALP were observed to be non-
significantly different from control animals.
Histopathological examination
We further confirmed the HYP-mediated liver damage and the effect 
of extract treatment on it through histopathological examination of 
the liver using hematoxylin-eosin staining. We observed a normal 
architecture of hepatic cells in control animals, cells appeared to be 
healthy and had a normal physiological appearance with no signs of 
damage or cytotoxicity. We further observed a marked liver damage in 
animals subjected to HYP. Cellular morphology was distorted and signs 
of significant cell death, cellular damage, and necrosis were observed 
in these animals. Treating hypoxic animals with plant extract resulted 
in significant hepatoprotective effect, which was comparable at both 
the treatment doses. Hepatic cells appeared healthy with significantly 
lesser signs of cellular damage, cell death, and necrosis when compared 
to HYP. Extract treatment efficiently protected HYP-mediated cellular 
damage in the liver. Moreover, S. chirata was not having any hepatotoxic 
effect of its own at the given doses as indicated by the normal cellular 
morphology and histopathological appearance of control animals 
treated with the plant extract which was comparable to control.
DISCUSSION
The present investigation demonstrated the antioxidant and 
hepatoprotective potential of hydroalcoholic extract of S. chirata 
against HYP-induced oxidative stress in Wistar rats. During HYP, an 
excessive amount of ROS is generated by the mitochondria which lead 
to the development of oxidative stress. Once ROS formation exceeds 
the neutralizing capacity of antioxidants present in our body, these 
highly reactive free radicals react with biomolecules such as lipid, 
protein, and DNA which lead to cellular dysfunction [3,5]. ROS disrupts 
the functions of the cellular membrane by interacting with membrane 
phospholipids and inducing lipid peroxidation [3,5,15]. Our biological 
system is having natural antioxidants in the form of catalase and GSH, 
which efficiently neutralize the ROS and protects biomolecules from 
ROS-mediated damage.
However, these antioxidants are saturable and during excessive oxidative 
stress, as observed during HYP, fails to impart complete protection and 
adverse effects of oxidative stress are inflicted [3,5,13-16]. Oxidative 
stress is associated with the development of hepatotoxicity [5], 
cellular damage [18], necrosis [18], apoptosis [19], and disorders 
such as dementia and Alzheimer’s [20]. Previous reports suggest 
that the hypoxic state is associated with the development of hepatic 
toxicity and impaired hepatic functions [5,21]. Our results are in 
agreement with these reports and we have demonstrated that HYP 
is associated with enhanced oxidative stress and hepatotoxicity. 
Therapeutic interventions of natural origin which are capable of 
attenuating oxidative stress are known to exert hepatoprotective and 
other beneficial effects [22-24]. Our findings are in line with these 
reports and we demonstrated that hydroalcoholic extract of S. chirata 
possesses strong antioxidant potential as indicated by the reduced 
ROS generation, improved catalase activity, enhanced GSH levels, and 
inhibition of lipid peroxidation (Fig. 1), which was associated with the 
improved hepatic functions.
Plants and herbal preparations are well-known sources of bioactive 
antioxidants such as flavonoids, which have been reported to be 
beneficial during various indications such as hepatotoxicity [22-24]. 
Phytochemical screening of the hydroalcoholic extract of S. chirata 
revealed the presence of a high amount of flavonoids, which may be 
responsible for its antioxidant and hepatoprotective potential. S. chirata 
is an important medicinal plant and it has been used traditionally 
for the management of various ailments such as hepatotoxicity [25]. 
Likewise, various herbal preparations are well documented for their 
hepatoprotective potential and are known to exert their beneficial 
effects by improving the morphology and biochemical profile of 
liver [26-28]. SGOT, SGPT, and ALP are the biomarkers of liver damage 
and are elevated during liver toxicity [29]. HYP is known to elevate 
these enzymes and induce morphological changes in the liver [30]. 
Various herbal preparations impart their hepatoprotective effects 
by reducing the levels of these enzymes [11,26,31,32] and improving 
cellular morphology [26-28]. Our results are in agreement with these 
reports. We have demonstrated that HYP-induced marked cellular 
damage in the liver which was associated with cellular damage and 
significantly elevated hepatic enzymes (Figs. 2 and 3). Moreover, like 
previously reported herbal preparations, S. chirata efficiently improved 
liver morphology and improved the biochemical profile of the liver. 
These results suggest that hydroalcoholic extract of S. chirata is having 
marked hepatoprotective potential which can be attributed to its 
potential to alleviate HYP-induced oxidative stress in the biological 
system.
CONCLUSION
HYP is associated with the development of hepatic damage, enhanced 
oxidative stress, altered hepatic morphology, and disrupted hepatic 
biochemical profile in Wistar rats. The hydroalcoholic extract of 
S. chirata demonstrated marked hepatoprotective potential which was 
associated with the attenuation of HYP-mediated oxidative stress. Our 
finding provides an experimental justification for the traditional use of 
this plant during the liver disorders. Moreover, herbal preparations are 
safe to use and may find a clinical application for the management of 
hepatic ailments associated with oxidative stress. These findings are 
preliminary and need to be evaluated further.
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Fig. 3: Effect of Swertia chirata treatment on hypoxia (HYP)-
induced liver damage. Histopathological examination of liver 
using hematoxylin-eosin staining. Red arrow indicates the 
damage regions on the histopathological sections. CTRL - control; 
CTRL 50 - control+50 mg/kg extract; CTRL 100 - control+100 mg/
kg extract; HYP - hypoxia ; HYP 50 - HYP+50 mg/kg extract; HYP 
100 - HYP+100 mg/kg extract
